Translating Your Research into Viable Drug Discovery Projects Through the Cyclica Academic Partnership Program (CAPP) – June 7, 2022
The Cyclica Academic Partnership Program (CAPP) (https://www.cyclicarx.com/capp) connects academic labs and faculties with Cyclica’s AI-augmented drug discovery platform through in-kind use, while sharing both risks and benefits. Together with academic partners, Cyclica unlocks the therapeutic potential of target discovery research to generate novel small molecule therapeutics for Oncology, CNS Disorders, and Inflammatory Diseases. During this […]